A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has made a breakthrough in gastric ...

Pathway to Cures, the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), is pleased to announce its investment in SeraGene Therapeutics, a pioneering biotechnology company ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates in healthcare-adjacent markets by delivering access to clinical care and wellness services through a digital, ...

Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...

The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal ...

BioArctic AB Class B ( ($SE:BIOA.B) ) just unveiled an announcement. Eisai, in partnership with BioArctic AB, has completed the rolling submission ...

The Battle of Princeton is “an unbelievable powerful story and a moving story.” That is why the undergoing restoration work – ...

A live audio webcast of the event will be available online at Erasca.com/events. An archived replay of the event will be available for 30 days following the webcast at Erasca.com/events.

Recent polling shows oncologists changing inclination in treatment for mHSPC based on tolerability profiles.

The phase 2 SANRECO study has recently completed enrollment and will evaluate divesiran, a potential therapy for patients ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...